Traderking60 there’s a press release on Intk web site that a few hours old discussing Q1 and a correction to expenses. Biotech123 posted here and stated that prior to launching into a senior exchange such as the NYSE a full 2 years of financials exceeding X and a share price of $4.00 per share again for 2 consecutive years prior must be exhibited. With that in mind how is it even remotely possible for intk to apply for NYSE status in Q1 of 2023? What are your thoughts about this announcements given what we believe to be accurate in Biotech123s posts